In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 1: Chronic Heart Failure – Epidemiology, Prognosis, Outcome
Session

Event : Heart Failure 2019

Topic : Other

  • Session type : Poster Session
  • Date : 25 May 2019
  • Time : 08:30 - 17:30

31 presentations in this session

Changes in the causes of death in a heart failure unit in Spain along 17 years

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : J Lupon (Badalona,ES)

Epidemiology and long-term outcome in outpatients with chronic heart failure in north-western europe

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : H Froehlich (Heidelberg,DE)

Identification of founder MYBPC3 gene mutations in hungarian patients with hypertrophic cardiomyopathy

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Tringer (Szeged,HU)

Trends in heart failure epidemiology between 2007 and 2016 in Piedmont, Italy: findings from the Epi-HF study

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : D Castagno (Torino,IT)

Prognostic value of handgrip strength in patients with heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : T Furlan (Trbovlje,SI)

Trends in incidence and survival in patients with heart failure in sweden: insights from swedish coronary angiography and angioplasty registry

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : E Omerovic (Gothenburg,SE)

Previous cardiomyopathy in cardiogenic shock

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : H Santos (Barreiro,PT)

Revisiting the obesity paradox in heart failure: percent body fat as predictor of biomarkers and outcome

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Aimo (Pisa,IT)

Prognostic significance of obesity after ST-elevation myocardial infarction: the impact on heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : R Costa (Porto,PT)

Comparative analysis of multiparametric scores in heart failure: does the type of follow-up matter?

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : J AGOSTINHO (Lisboa,PT)

Heart failure in healthy young people with left bundle branch block: long-term follow-u

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : L Rivetti (Conegliano,IT)

Impact of recurrent heart failure hospitalizations on cardiovascular mortality in patients with heart failure in CPRD, a UK database

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : R Lahoz (Basel,CH)

Direct costs of heart failure in a portuguese population.

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : C Fonseca (Oeiras,PT)

Differences between diabetics and non-diabetics with chronic heart failure and its impact on prognosis

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : L Spinarova (Brno,CZ)

Prognostic nutrition index predicts prognosis in ultra-elderly patients with heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : T Kawata (Tokyo,JP)

Co-morbid conditions and their relationship with mortality in elderly heart failure patients

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : V Larina (Moscow,RU)

Heart failure whit preserved ejection fraction (HFpEF); a mexican cohort

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : J Magana Serrano (Mexico,MX)

Frailty and prognosis in heart failure. A prospective study with a quick and self-administered scale.

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : JD Sanchez Vega (Madrid,ES)

Snapshot evaluation of heart failure in Turkey: baseline characteristics of SELFIE-TR

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : MB Yilmaz (Izmir,TR)

Epidemiology of heart failure: incidence, prevalence, and risk factors from a systematic review

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : CS Lam (Singapore,SG)

A multicenter brazilian cohort to optimize heart failure treatment using an organized multidisciplinary approach - Optimize Brazil

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : R Mourilhe Rocha (Rio De Janeiro,BR)

Prevalence and prognostic association of hyperuricemia in heart failure patients with reduced ejection fraction

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : D Seabra (Vila Do Conde,PT)

Echocardiographic features of ultra-elderly heart failure patients in Japan: secondary tricuspid regurgitation due to atrial fibrillation

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : T Kawata (Tokyo,JP)

Epidemiology of atrial fibrillation among heart failure patients according to ejection fraction.

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Rakisheva (Almaty,KZ)

Gender differences in heart failure with mid-range ejection fraction patients

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : JH Choi (Pusan,KR)

Capability for self-care of patients with heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Mlynarska (Myslowice,PL)

Heart failure in women: insights from de RECOLFACA registry

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : CI Saldarriaga (Medellin,CO)

Prognostic value of depression, anxiety disorders and inflammatory markers in patients with heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : E Gazi (Canakkale,TR)

The difference in association of atrial fibrillation and sinus rhythm with heart failure with reduced, mid-range and preserved ejection fraction.

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Isabekova (Almaty,KZ)

Correlation of endorgan function and bioimpedance measurement in patients with advanced heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : L Roehrich (Berlin,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are